You are here
COCAINE THERAPEUTIC: PD2005 DOPAMINE TRANSPORT INHIBITOR
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43DA018009-01
Agency Tracking Number: DA018009
Amount:
$136,520.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Timeline
Solicitation Year:
2004
Award Year:
2004
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
PHASE 2 DISCOVERY, INC.
3130 HIGHLAND AVE, 3RD FL
CINCINNATI, OH
45219
United States
DUNS:
N/A
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: FRANK Zemlan
Phone: (513) 475-6618
Email: FZEMLAN@PHASE2D.COM
Phone: (513) 475-6618
Email: FZEMLAN@PHASE2D.COM
Business Contact
Name: JAMES HILLARD
Phone: (513) 475-6618
Phone: (513) 475-6618
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The National Institute of Drug Abuse has indicated, "NIDA's top research priority is to find a medication to block or greatly reduce the effects of cocaine to be used as part of a comprehensive treatment program." The
* Information listed above is at the time of submission. *